Emergent Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was USD 0.20121 million. Net loss was USD 1.12 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | +7.14% | +7.14% | +114.29% |
2023 | Emergent Health Corp. Appoints Charlie McMenamin to Its Board of Director | CI |
2023 | Emergent Health Corp agreed to acquire Nanosthetic Corp. | CI |